These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34477535)
21. The inner ear and the neurologist. Agrup C; Gleeson M; Rudge P J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):114-22. PubMed ID: 17229743 [TBL] [Abstract][Full Text] [Related]
22. Development of a drug delivery system for the inner ear using poly(amino acid)-based nanoparticles. Kim DK; Park SN; Park KH; Park CW; Yang KJ; Kim JD; Kim MS Drug Deliv; 2015 May; 22(3):367-74. PubMed ID: 24447111 [TBL] [Abstract][Full Text] [Related]
23. Diseases and targets for local drug delivery to the inner ear. Lustig LR Hear Res; 2018 Oct; 368():3-9. PubMed ID: 29778289 [No Abstract] [Full Text] [Related]
24. Local drug delivery to the inner ear: Principles, practice, and future challenges. Plontke SK; Salt AN Hear Res; 2018 Oct; 368():1-2. PubMed ID: 30006112 [No Abstract] [Full Text] [Related]
25. Microsystems technologies for drug delivery to the inner ear. Pararas EE; Borkholder DA; Borenstein JT Adv Drug Deliv Rev; 2012 Nov; 64(14):1650-60. PubMed ID: 22386561 [TBL] [Abstract][Full Text] [Related]
26. Outlook and future of inner ear therapy. Devare J; Gubbels S; Raphael Y Hear Res; 2018 Oct; 368():127-135. PubMed ID: 29804723 [TBL] [Abstract][Full Text] [Related]
27. Intratympanic delivery of oligoarginine-conjugated nanoparticles as a gene (or drug) carrier to the inner ear. Yoon JY; Yang KJ; Kim DE; Lee KY; Park SN; Kim DK; Kim JD Biomaterials; 2015 Dec; 73():243-53. PubMed ID: 26414408 [TBL] [Abstract][Full Text] [Related]
28. Inner Ear Drug Delivery for Sensorineural Hearing Loss: Current Challenges and Opportunities. Liu SS; Yang R Front Neurosci; 2022; 16():867453. PubMed ID: 35685768 [TBL] [Abstract][Full Text] [Related]
29. Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice. Guo JY; He L; Qu TF; Liu YY; Liu K; Wang GP; Gong SS J Vis Exp; 2018 May; (135):. PubMed ID: 29889202 [TBL] [Abstract][Full Text] [Related]
30. Nanocarriers for Inner Ear Disease Therapy. Xu X; Zheng J; He Y; Lin K; Li S; Zhang Y; Song P; Zhou Y; Chen X Front Cell Neurosci; 2021; 15():791573. PubMed ID: 34924960 [TBL] [Abstract][Full Text] [Related]
31. [Topical drug administration to the inner ear. Modern state of the problem and development perspectives]. Kryukov AI; Kunelskaya NL; Shershunova EA; Rebrov IE; Yamshchikov VA; Garov EV; Tsarapkin GY; Mishchenko VV Vestn Otorinolaringol; 2019; 84(5):6-14. PubMed ID: 31793520 [TBL] [Abstract][Full Text] [Related]
32. Cochlear protein biomarkers as potential sites for targeted inner ear drug delivery. Naples JG; Miller LE; Ramsey A; Li D Drug Deliv Transl Res; 2020 Apr; 10(2):368-379. PubMed ID: 31741303 [TBL] [Abstract][Full Text] [Related]
33. Optimized phospholipid-based nanoparticles for inner ear drug delivery and therapy. Yang KJ; Son J; Jung SY; Yi G; Yoo J; Kim DK; Koo H Biomaterials; 2018 Jul; 171():133-143. PubMed ID: 29689410 [TBL] [Abstract][Full Text] [Related]
34. Probucol-bile acid nanoparticles: a novel approach and promising solution to prevent cellular oxidative stress in sensorineural hearing loss. Wagle SR; Kovacevic B; Foster T; Ionescu CM; Jones M; Mikov M; Wise A; Mooranian A; Al-Salami H J Drug Target; 2024 Aug; 32(7):737-755. PubMed ID: 38758361 [TBL] [Abstract][Full Text] [Related]
35. LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB). Shi X; Wang Z; Ren W; Chen L; Xu C; Li M; Fan S; Xu Y; Chen M; Zheng F; Zhang W; Zhou X; Zhang Y; Qiu S; Wu L; Zhou P; Lv X; Cui T; Qiao Y; Zhao H; Guo W; Chen W; Li S; Zhong W; Lin J; Yang S Signal Transduct Target Ther; 2022 Jun; 7(1):175. PubMed ID: 35680846 [TBL] [Abstract][Full Text] [Related]
36. Overcoming barriers: a review on innovations in drug delivery to the middle and inner ear. Delaney DS; Liew LJ; Lye J; Atlas MD; Wong EYM Front Pharmacol; 2023; 14():1207141. PubMed ID: 37927600 [TBL] [Abstract][Full Text] [Related]
37. Inner ear perfusion: indications and applications. Hoffmann KK; Silverstein H Curr Opin Otolaryngol Head Neck Surg; 2003 Oct; 11(5):334-9. PubMed ID: 14502063 [TBL] [Abstract][Full Text] [Related]
38. Local Delivery of Therapeutics to the Cochlea Using Nanoparticles and Other Biomaterials. Dash S; Zuo J; Steyger PS Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145336 [TBL] [Abstract][Full Text] [Related]
39. Recent advances in local drug delivery to the inner ear. El Kechai N; Agnely F; Mamelle E; Nguyen Y; Ferrary E; Bochot A Int J Pharm; 2015 Oct; 494(1):83-101. PubMed ID: 26260230 [TBL] [Abstract][Full Text] [Related]
40. [In vitro dexamethasone release from nanoparticles and its pharmacokinetics in the inner ear after administration of the drug-loaded nanoparticles via the round window]. Chen G; Hou SX; Hu P; Hu QH; Guo DD; Xiao Y Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):1022-4. PubMed ID: 18583254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]